Share on PinterestA brand new GLP-1 drug exhibits promise for enhancing metabolic well being and treating obesity-related ailments like liver illness. camacho9999/Getty Photographs A brand new weight reduction drug known as survodutide has proven promising ends in a part 3 medical trial. The drug, which stimulates GLP-1 and glucagon receptors, led to a 16.6% drop... Read More


:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-1179975153-63bb432bb0c044aca79c8f81a0717c34.jpg?w=600&resize=600,400&ssl=1)



:max_bytes(150000):strip_icc():format(jpeg)/Health-Stocksy_txpd4657e0cZOm300_Medium_5004560-914bb94903524b3ea49a3e6debfeff79.jpg?w=600&resize=600,400&ssl=1)




:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-951627744-59b49fa5b52d4df6bab43afb6c3fcfe4.jpg?w=160&resize=160,100&ssl=1)

:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)



Recent Comments